IDH1 and astrocytoma (excluding glioblastoma): More recently, the NADP+ -dependent enzyme IDH1 was found to be mutated in ∼70% of grade II and grade III astrocytomas and oligodendrogliomas, and secondary GBMs [57, 69, 70].